Active living program for early bladder cancer patients with their own bladder
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether a structured “active-living” program (helping you be more active in daily life) improves outcomes for people newly diagnosed with operable early bladder cancer. It may help with overall health and quality of life while you receive standard bladder cancer care without removing your bladder.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 20 years old
- Have newly diagnosed early bladder cancer that can be treated without bladder removal (keep your bladder)
- Know your diagnosis and are not planning to have cystectomy (bladder removal) right now
- Be able to talk and understand conversations with others
- Read and speak Mandarin/Chinese
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a patient's own tumor cells grown in a lab (organoids) can help doctors choose the best chemotherapy drugs before bladder cancer surgery. It may help find the most effective treatment for you.
This trial tests a new type of radiation therapy that adjusts to your body's changes during treatment. It aims to reduce side effects and improve accuracy for people with bladder cancer.
This trial tests an AI-assisted camera system that looks inside the bladder to help find bladder cancer. It may help diagnose cancer more accurately during a routine procedure.
This trial tests if using a patient's own tumor cells grown in a lab (organoids) can help choose the best chemotherapy to put directly into the bladder. It is for people with non-muscle invasive bladder cancer who need their first round of this treatment.
This trial tests whether artificial intelligence (AI) can help guide surgeons during a procedure called TURBT to remove early-stage bladder cancer. The goal is to see if this technology improves the removal of cancer while potentially reducing risks.
This study tests a urine test that may help find bladder cancer early without needing invasive procedures. It is for people with high-grade or high-risk non-muscle-invasive bladder cancer who are receiving or have received BCG treatment.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.